Bioventix Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Bioventix için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Biotechs kazanç büyümesi	37.3%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Low
Son güncelleme	28 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Estimating The Fair Value Of Bioventix PLC (LON:BVXP)

Jun 19

Bioventix's (LON:BVXP) Dividend Will Be £0.68

Mar 29

We Think Shareholders May Consider Being More Generous With Bioventix PLC's (LON:BVXP) CEO Compensation Package

Dec 01

Shareholders of Bioventix (LON:BVXP) Must Be Delighted With Their 364% Total Return

Jan 31

Is Bioventix PLC (LON:BVXP) Popular Amongst Insiders?

Jan 18

Is Bioventix PLC's (LON:BVXP) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 06

Here's How We Evaluate Bioventix PLC's (LON:BVXP) Dividend

Dec 23

Does Bioventix's (LON:BVXP) CEO Salary Compare Well With Industry Peers?

Nov 28

Kazanç ve Gelir Büyüme Tahminleri

AIM:BVXP - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (GBP Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2025	15	9	8	11	1
6/30/2024	14	8	8	8	N/A
3/31/2024	14	8	8	8	N/A
12/31/2023	14	9	8	8	N/A
9/30/2023	13	9	8	8	N/A
6/30/2023	13	8	8	8	N/A
3/31/2023	13	8	8	8	N/A
12/31/2022	13	8	8	8	N/A
9/30/2022	12	8	8	8	N/A
6/30/2022	12	8	8	8	N/A
3/31/2022	11	7	7	7	N/A
12/31/2021	10	7	7	7	N/A
9/30/2021	11	7	6	7	N/A
6/30/2021	11	7	6	6	N/A
3/31/2021	11	7	6	7	N/A
12/31/2020	10	7	7	7	N/A
9/30/2020	10	7	7	7	N/A
6/30/2020	10	7	7	8	N/A
3/31/2020	10	7	7	7	N/A
12/31/2019	10	7	6	7	N/A
9/30/2019	10	6	6	6	N/A
6/30/2019	9	6	6	6	N/A
3/31/2019	9	6	6	6	N/A
12/31/2018	9	6	6	6	N/A
9/30/2018	9	6	6	6	N/A
6/30/2018	9	6	6	6	N/A
3/31/2018	9	6	N/A	5	N/A
12/31/2017	8	6	N/A	5	N/A
9/30/2017	8	5	N/A	4	N/A
6/30/2017	7	5	N/A	4	N/A
3/31/2017	7	5	N/A	4	N/A
12/31/2016	6	4	N/A	4	N/A
9/30/2016	6	4	N/A	3	N/A
6/30/2016	6	3	N/A	3	N/A
3/31/2016	5	3	N/A	3	N/A
12/31/2015	5	3	N/A	2	N/A
9/30/2015	5	3	N/A	2	N/A
6/30/2015	4	3	N/A	2	N/A
3/31/2015	4	2	N/A	2	N/A
12/31/2014	4	2	N/A	2	N/A
9/30/2014	4	2	N/A	2	N/A
6/30/2014	4	2	N/A	2	N/A
3/31/2014	3	2	N/A	2	N/A
12/31/2013	3	2	N/A	2	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: BVXP 'un tahmini kazanç büyümesinin tasarruf oranının ( 1.9% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: BVXP 'un kazançlarının UK pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: BVXP şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: BVXP şirketinin gelirinin UK pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: BVXP şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: BVXP 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Bioventix Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased to UK£43.00

Price target increased to UK£43.00

Recent updates

Final dividend of UK£0.87 announced

Full year 2024 earnings: EPS and revenues miss analyst expectations

New minor risk - Financial data availability

Estimating The Fair Value Of Bioventix PLC (LON:BVXP)

Bioventix's (LON:BVXP) Dividend Will Be £0.68

First half dividend increased to UK£0.68

First half 2024 earnings released: EPS: UK£0.77 (vs UK£0.72 in 1H 2023)

Now 22% overvalued after recent price rise

We Think Shareholders May Consider Being More Generous With Bioventix PLC's (LON:BVXP) CEO Compensation Package

Bioventix PLC, Annual General Meeting, Dec 07, 2023

Upcoming dividend of UK£0.90 per share at 4.5% yield

Bioventix PLC Announces Second Interim Dividend, Payable on 24 November 2023

Full year 2023 earnings released: EPS: UK£1.61 (vs UK£1.47 in FY 2022)

New minor risk - Financial data availability

Bioventix plc Appoints Joanne (Jo) Pisani to the Board as an Independent Non-Executive Director

Independent Non-Executive Chairman recently sold UK£97k worth of stock

Bioventix (LON:BVXP) Is Increasing Its Dividend To £0.62

Upcoming dividend of UK£0.62 per share at 3.9% yield

First half 2023 earnings released: EPS: UK£0.72 (vs UK£0.57 in 1H 2022)

CEO & Director recently sold UK£2.2m worth of stock

Price target increased to UK£43.00

Bioventix PLC, Annual General Meeting, Dec 08, 2022

Upcoming dividend of UK£1.00 per share

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Bioventix PLC Announces Second Interim Dividend for the Year Ended 30 June 2022, Payable on 18 November 2022

Bioventix PLC to Report Fiscal Year 2022 Results on Oct 24, 2022

Price target increased to UK£43.00

Upcoming dividend of UK£0.52 per share

Bioventix (LON:BVXP) Is Increasing Its Dividend To UK£0.52

First half 2022 earnings released

Bioventix PLC Announces First Interim Dividend, Payable on 22 April 2021

Upcoming dividend of UK£1.00 per share

Full year 2021 earnings released: EPS UK£1.29 (vs UK£1.39 in FY 2020)

First half 2021 earnings released: EPS UK£0.59 (vs UK£0.67 in 1H 2020)

Should Bioventix PLC (LON:BVXP) Be Part Of Your Dividend Portfolio?

Is Now The Time To Put Bioventix (LON:BVXP) On Your Watchlist?

What Does Bioventix's (LON:BVXP) CEO Pay Reveal?

Shareholders of Bioventix (LON:BVXP) Must Be Delighted With Their 364% Total Return

New 90-day high: UK£44.65

Is Bioventix PLC (LON:BVXP) Popular Amongst Insiders?

Is Bioventix PLC's (LON:BVXP) Latest Stock Performance Being Led By Its Strong Fundamentals?

New 90-day high: UK£44.00

Here's How We Evaluate Bioventix PLC's (LON:BVXP) Dividend

Does Bioventix's (LON:BVXP) CEO Salary Compare Well With Industry Peers?

Full year 2020 earnings released: EPS UK£1.39

Revenue and earnings beat expectations

Bioventix PLC, Annual General Meeting, Dec 10, 2020

Annual earnings released: Revenue and earnings beat expectations

Full year earnings released - EPS UK£1.39

New 90-day high: UK£42.75

Bioventix plc Announces Treena Turner Steps Down from the Board

Bioventix to Be Deleted from Other OTC

New 90-day low - UK£40.75

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin